NEW YORK, Dec. 20 - Celera Genomics has licensed its genomic databases to Serono, Europe's largest biotech firm, Celera said on Thursday.
Financial terms of the multi-year subscription agreement were not disclosed.
"This agreement is another important element in our expanding genomics program," said Silvano Fumero, senior executive vice president for research and pharmaceutical development at Serono. He added that the Applera unit's mouse and human genome sequences "will support Serono's scientific efforts to discover novel targets and therapeutic proteins."
Serono, considered the third-largest biotech in the world in revenue, is based in Geneva.